Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - Phospholipase - BIRM 271

BIRM 271

CAS No. 149106-77-4

BIRM 271( —— )

Catalog No. M37008 CAS No. 149106-77-4

BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 551 In Stock
100MG 762 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    BIRM 271
  • Note
    Research use only, not for human use.
  • Brief Description
    BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
  • Description
    BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. BIRM 271 and BIRM 270 are enantiomers that inhibit the production of leukotriene B4 with IC50 of 40 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Phospholipase | LTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149106-77-4
  • Formula Weight
    335.44
  • Molecular Formula
    C21H25N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N([C@H](CC1CCCCC1)C2=CC=CC=N2)C=3OC=4C(N3)=CC(C)=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • VU0359595

    VU0359595 (ML-270) is a potent and selective pharmacological phospholipase D1 (PLD1) inhibitor with an IC50 of 3.7 nM. VU0359595 is >1700-fold selective for PLD1 over PLD2 (IC50 of 6.4 μM).

  • CAY10594

    CAY10594 is a potent phospholipase D2(PLD2) inhibitor. CAY10594 ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.

  • CCR1/5/8 activator 1

    CCR1/5/8 activator 1 is a cytoplasmic phospholipase A inhibitor with antifungal activity.

Sign In Join Free